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Human bladder cancer is nearly 3 times more common in men than in women.  In
general, the sex difference in incidence of human bladder carcinoma is considered to be
due to industrial and environmental carcinogens or other factors, though there is no
clear evidence supporting this.  We suspected that the sex difference in incidence of
bladder carcinoma might be due to the effects of testosterone.  We investigated the
effects of testosterone on mouse bladder carcinogenesis by using immunohistochemical
staining and terminal-deoxynucleotidyl-transferase (TdT)-mediated dUTP-biotin nick
end labeling (TUNEL).  A total of 94 four-week-old male mice were divided into 3
groups.  In Group I, castration was carried out, then 0.05% N-butyl-N-(4-hydroxy-
butyl)nitrosamine (BBN) was administered until the end of the experiment.  In Group
II, 0.05% BBN was administered similarly, without castration.  In Group III, 0.05%
BBN was administered similarly, without castration, and 3 mg/kg of testosterone was
injected intramuscularly weekly from the beginning of the experiment.  All mice were
cystectomized at the end of the experimental period to investigate the incidence of bladder
cancer, and immunohistochemical staining and TUNEL were performed to examine
the correlation between cell proliferation and apoptosis.  Among the 3 groups, occurrence
of bladder tumor was most frequent in Group III, and tumor induction time was the
shortest.  The proliferation index for tumors significantly increased as the stage and
grade progressed.  On the other hand, the apoptotic index for tumors significantly
decreased.  The proliferation index was the highest in Group III and the lowest in Group
I.  A significant difference in the proliferation index was observed among the 3 groups.
No significant difference was observed in the apoptotic index among the 3 groups.  Our
results indicate that the effect of testosterone on mouse bladder carcinogenesis is more
significantly related to cell proliferation than to suppression of apoptosis, with the result
that testosterone promotes the occurrence of BBN-induced mouse bladder carcinomas.
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The fact that the incidence of human urinary
bladder carcinoma is higher in males than in
females has often been reported in the literature.
It has been concretely established that the male-
to-female ratio among patients is about 3:1
(Laor et al., 1984; Yamada et al., 1986).  How-
ever, there is no clear evidence why gender
results in different incidences of urinary blad-
der tumors.  In general, the cause of sex differ-
ence in incidence of human bladder carcinogen-
esis is believed to be from industrial and envi-
ronmental factors.  Although over the past 30
years, women have joined the male-predominant
workplace, changed their habits and been ex-
posed to both industrial and environmental car-
cinogens, new cases of human bladder cancer in
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United States still show no
statistical change, and bladder
cancer still remains about 3
times more common in men
than in women (Messing and
Catalona, 1998).  We consid-
ered that sex difference in
bladder carcinogenesis might
be related to sex hormones,
and specifically to testoster-
one, and decided to investi-
gate the influence of testoster-
one on bladder carcinogene-
sis.
One of the most important
molecular mechanisms in the
process of carcinogenesis is
apoptosis.  Apoptosis is a
morphologically and bio-
chemically distinct form of
cell death, and its major
mechanism is the maintenance of homeostasis
and the balance of cell proliferation in normal
and malignant cells (Kerr et al., 1972, 1994).
Terminal-deoxynucleotidyl-transferase (TdT)-
mediated dUTP-biotin nick end labeling
(TUNEL) has been successfully used to detect
apoptotic cells in routine paraffin-embedded
sections (Gavrieli et al., 1992).
Thus, we investigated whether testosterone
influenced mouse bladder carcinogenesis and
analyzed the relationship between cell prolif-
eration and apoptosis by using immunohisto-
chemical staining and TUNEL.
Materials and Methods
A total of 94 four-week-old male C57BL/6 mice
(Shimizu, Kyoto, Japan) were housed 5 to 6 per
plastic cage with hardwood chips for bedding,
in an air-conditioned room at 23 ± 2˚C and 60 ±
10% humidity with a 12-h light-dark cycle.
They were divided at random into 3 groups of
30 to 33 mice each.  N-butyl-N-(4-hydroxy-
butyl) nitrosamine (BBN) (Tokyo Kasei,
Tokyo, Japan) was dissolved in tap water to
concentrations of 0.05%, and was added to a
few drops of Tween 80 (Wako, Osaka, Japan).
0.05% BBN was supplied to each group begin-
ning at 5 weeks of age.
Experiment I
A total of 44 male mice were investigated in
Experiment I.  In Group I, castration was car-
ried out under ether anesthesia at 4 weeks, and
from 5 weeks of age, mice were administered
0.05% BBN orally for a period of 18 weeks.  In
Group II, mice were administered 0.05% BBN
as described above, without castration, from 5
weeks of age, for a period of 18 weeks.  In
Group III, castration was not performed, and
from 5 weeks of age, 0.05% BBN was given as
described, and 3 mg/kg (body weight) of testos-
terone propionate (Enarmon-oil, Teikokuzoki,
Tokyo) was injected intramuscularly once
weekly for a period of 18 weeks.  All mice were
cystectomized on the 18th week (Fig. 1).
Experiment II
A total of 50 male mice were investigated in
Experiment II.  Mice were divided into 3
groups and housed as described in Experiment
I.  All mice were cystectomized at the end of
the different experimental period because we
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Fig. 1.  Experimental protocol.  In Group I, castration is carried out
and 0.05% N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) is
administered.  In Group II, 0.05% BBN is similarly administered.  In
Group III, 0.05% BBN is administered and 3 mg/kg of testosterone is
injected intramuscularly weekly.  Mice are cystectomized at the end
of each experimental period.  wk, weeks.
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believed that the difference in cystectomized
period results in no significant difference in
tumor stage and tumor grade among the 3
groups.  Thus in Group I, mice were cystec-
tomized in groups of 3 to 5 from the 28th to the
33rd week, in Group II, from the 23rd to the
27th week and in Group III, from the 21st to the
24th week (Fig. 1).
In Experiments I and II, all mice were cys-
tectomized under ether anesthesia to investigate
the incidence of bladder cancer.  All tissue
specimens were fixed by an injection of about
0.10 to 0.15 mL of 10% formalin into the lu-
men, and immersed in the same solution.  After
fixation, each specimen was cut into 4 sections
and embedded in paraffin, and a series of 3-
µm thick sections was prepared for hematoxy-
lin and eosin staining, immunohistochemical
staining and TUNEL.
Immunohistochemical staining of prolif-
erating cell nuclear antigen (PCNA)
Immunohistochemical staining was performed
with a Histofine SAB-PO kit (Nichirei, Tokyo).
Paraffin-embedded sections were placed on
silane-coated glass slides and air-dried at room
temperature.  Deparaffinized and rehydrated
sections were heated by microwave oven at
92˚C for 10 min, and then cooled for 60 min at
room temperature.  Endogenous peroxidase
activity was inhibited by incubation with 3%
hydrogen peroxidase in methanol for 20 min.
After blocking nonspecific reactions with 10%
normal rabbit serum, the sections were incubat-
ed with a monoclonal antibody against PCNA
(DAKO, Glostrup, Denmark) with 1:200 dilu-
tion at 4˚C overnight.  The sections were then
incubated with biotinylated rabbit anti-mouse
immunoglobulin for 30 min, followed by incu-
bation with streptavidin-peroxidase complex
for 30 min and rinsed with several changes of
phosphate-buffered saline between steps.  The
color was developed with diaminobenzidine
solution.  Finally, they were lightly counter-
stained with hematoxylin.
TUNEL
TUNEL was performed by using an Apop Tag
Plus in situ apoptosis detection kit (Intergen,
New York, NY).  In brief, paraffin sections
were de-waxed, rehydrated through a graded
alcohol series and washed with distilled water.
Subsequently, tissues were digested with 40
µL/mL proteinase K (Wako) at 37˚C for 80
min, because proteinase K is known to enhance
positive nuclear labeling in apoptotic cells.
After prehybridization treatment, the sections
were incubated with TdT and digoxigenin-
dUTP in a moist chamber for 90 min at 37˚C.
Incubation with anti-digoxigenin-antibody-
peroxidase for 30 min at room temperature was
employed for detection of digoxigenin-dUTP
labeling.  The color was developed with di-
aminobenzidine solution and counterstained
with hematoxylin or methyl green.
The proliferation and apoptotic indices
PCNA-positive cells were used to quantify the
proliferation index (percentage of PCNA-posi-
tive cells in 1000 cells).  Similarly, TUNEL-
positive cells were used to quantify the apopto-
tic index (percentage of TUNEL-positive cells
in 1000 cells).  In benign lesions and carcino-
mas in situ, the proliferation and apoptotic indi-
ces were measured in the mucosal layers, and in
invasive carcinomas, counted at the infiltrative
layers.
Statistics
The difference for occurrence of bladder tumor
in Experiment I was analyzed with the Kruskal-
Wallis rank test.  The distribution of histologi-
cal stages, tumor grades and tumor induction
times in Experiment II was analyzed with the
one-way analysis of variance.  The relationship
of the proliferation or apoptotic index to the
stage and grade was examined with the Kruskal-
Wallis rank test.  The correlation between the
proliferation index and the apoptotic index was
analyzed by using a Pearson’s correlation coef-
ficient.  A level of P < 0.05 was regarded as
statistically significant.
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Results
Experiment I
A total of 44 mice were cystectomized in the
18th week.  Occurrence of urinary bladder can-
cer was 13.3% (1 carcinoma in situ; 1 invasive
carcinoma) in 15 mice from Group I, 64.3% (6
carcinomas in situ; 3 invasive carcinomas) in 14
mice from Group II and 80.0% (7 carcinomas in
situ; 5 invasive carcinomas) in 15 mice from
Group III.  Statistically significant differences
were found among the 3 groups (P < 0. 001)
(Table 1).
Experiment II
A cumulative total of 50 mice were cystecto-
mized between the 28th and 33rd week in
Group I, between the 23rd and 27th week in
Group II and between the 21st and 24th week in
Group III.  Occurrence of invasive bladder
cancer was 72.2% in Group I, 82.4% in Group
II and 86.7% in Group III.  No significant
distribution of cases was observed according to
the histological stage and grade of tumors in the
3 groups.  The tumor induction time was a mean
of 30.3 weeks in Group I, 25.4 weeks in Group
II and 22.8 weeks in Group III.  A significant
difference in tumor induction time was found
among the 3 groups (P < 0. 001) (Table 1).
The proliferation and apoptotic  indices
The relationship between the mean prolifera-
tion index and the stage of tumors is shown in
Table 2.  In each group, the proliferation index
significantly increased as the tumor stage
progressed.  In invasive carcinomas, a signifi-
cant difference in the proliferation index was
observed among the 3 groups (P = 0. 005).  The
relationship between the proliferation index and
the grade of invasive carcinomas is shown in
Table 3.  In Groups I and III, the proliferation
index significantly increased as the tumor grade
increased.  In Group II, no significant differ-
ence of the proliferation index was observed,
though values tended to increase as mentioned
above.  In every grade of tumor, a significant
difference in the proliferation index was found
among the 3 groups.  The relationships between
the mean apoptotic index and the tumor stage or
grade are shown in Tables 4 and 5, respectively.
In each group, the apoptotic index significantly
Table 1.  Occurrence of bladder tumors in Experiment I and invasive tumor induction time in
Experiment II
Group I GroupII Group III Statistical analysis
Occurrence of bladder tumor (%) 13.3 64.3 80.0 P < 0.001†
Invasive tumor induction time (week) 30.3 25.4 22.8 P < 0.001‡
† Kruskal-Wallis rank test.
‡ One-way analysis of variance.
Table 2.  Relationship between the proliferation index and the stage of tumors
Benign lesion Carcinoma Invasive Statistical analysis†
(%) in situ (%) tumor (%)
Group I 1.1   6.7     17.1 P < 0.001
Group II 0.2   6.4     31.0 P < 0.001
Group III 1.1 13.2     42.7 P < 0.001
Statistical analysis NS  NS P = 0.005
† Kruskal-Wallis rank test.
NS, not significant.
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Table 3.  Relationship between the proliferation index and the grade of tumors
Grade 1 (%) Grade 2 (%) Grade 3 (%) Statistical analysis†
Group I       9.9 16.1 25.3 P = 0.035
Group II     24.7 26.3 41.2       NS
Group III     14.0 33.0 71.4 P = 0.001
Statistical analysis P = 0.012  P = 0.039 P = 0.004
† Kruskal-Wallis rank test.
NS, not significant.
Table 4.  Relationship between the apoptotic index and the stage of tumors
Benign lesion Carcinoma Invasive Statistical analysis†
(%) in situ (%) tumor (%)
Group I 54.0 51.3 26.7 P = 0.001
Group II 64.5 43.5 21.4 P < 0.001
Group III 69.0 36.3 18.8 P = 0.009
Statistical analysis  NS  NS  NS
† Kruskal-Wallis rank test.
NS, not significant.
Table 5.  Relationship between the apoptotic index and the grade of tumors
Grade 1 (%) Grade 2 (%) Grade 3 (%) Statistical analysis†
Group I 35.4 39.3 8.0 P = 0.010
Group II 28.5 28.7 8.2 P = 0.042
Group III 36.4 21.9 5.1 P = 0.006
Statistical analysis NS NS NS
† Kruskal-Wallis rank test.
NS, not significant.
decreased as the stage and grade progressed.
No significant difference in apoptotic index was
found among the 3 groups.  Examples shown in
Figs. 2, 3 and 4 are a benign lesion in Group II,
a Grade-3 invasive bladder carcinoma in Group
I and a Grade-3 invasive bladder carcinoma in
Group III, respectively.
Correlation between the proliferation in-
dex and apoptotic index
The correlation between the proliferation index
and apoptotic index is shown in Fig. 5.  A nega-
tive significant correlation was observed (r =
–0.7, P < 0.001).
Discussion
Druckrey et al. (1964) first reported that oral
administration of BBN in rats induced bladder
carcinoma only organotrophically.  Since
then, some investigators have reported on
histogenetic studies of urinary bladder tumors
in various animals induced by BBN (Kakizoe,
1995).  In the 1970’s, several reports indi-
cated hormonal effects on the sex difference
in the incidence of bladder carcinogenesis.
Some of these studies showed that the oc-
currence of bladder carcinoma in animal
models induced by BBN is higher in males
than in females (Bertram and Craig, 1972;
Iriya, 1979).  Others have shown that testos-
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terone promotes the occurrence
of bladder carcinomas, and that
diethylstilbestrol suppresses it in
BBN-induced rats (Okajima et
al., 1975; Kono et al., 1975).
However, at present there is no
clear evidence to explain these
hormonal influences on urinary
bladder carcinogenesis.  In gene-
ral, the effects of human bladder
carcinogenesis are considered to
be due to industrial and environ-
mental carcinogens (Risch et al.,
1995) such as aniline dye, ciga-
rette smoking, etc., and hormonal
influence is considered neglig-
ible.  Recently, few reports have
appeared on hormonal effects in
bladder carcinogenesis.  It was esti-
mated that, in 1995, among 50,500
new cases of human bladder can-
cer diagnosed in the United States,
the incidence was about 3 times
more common in men than in wo-
men (Wingo et al., 1995).  Over
the past 30 years, women have
joined the male-predominant
workplace, changed their habits
and have subsequently been ex-
posed to both industrial and envi-
ronmental carcinogens, but sur-
prisingly, this sex difference in
the number of new cases of hu-
man bladder cancer remains
(Messing and Catalona, 1998).
We considered that hormonal in-
fluence, especially of testoster-
one, might relate to this contra-
dictory sex difference in inci-
dence, and that the hormonal in-
fluence on bladder carcinogene-
sis should be investigated.
Human bladder carcinomas
can be classified into papillary
superficial bladder carcinoma
and non-papillary invasive blad-
der carcinoma.  The former fre-
quently recurs after treatment
such as transurethral resection or
Fig. 2.  A benign bladder lesion in Group II.  a:  Hematoxylin and
eosin staining.  b:  A few proliferating cell nuclear antigen-positive
cells shown by immunohistochemical staining.  c:  A number of
apoptotic cells shown by terminal-deoxynucleotidyl-transferase
(TdT)-mediated dUTP-biotin nick end labeling, × 200.
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Fig. 3.  A Grade-3 invasive bladder carcinoma in Group I.  d:  Hem-
atoxylin and eosin staining.  e:  Proliferating cell nuclear antigen-
positive cells shown by immunohistochemical staining.  f:  Some
apoptotic cells shown by terminal-deoxynucleotidyl-transferase
(TdT)-mediated dUTP-biotin nick end labeling, × 200.
coagulation, but its prognosis is
good.  The latter frequently shows
metastasis and has a very poor
prognosis and many problems.
Most of the previous studies re-
ported the sex hormone influence
on urinary bladder carcinogenesis
in the rat model.  In all BBN-treated
rat strains, bladder carcinomas are
usually papillary, multiple and
superficial.  Thus bladder carci-
nomas in rats are a satisfactory
model for studying papillary su-
perficial bladder carcinomas in
humans (Ito et al., 1975).  On the
other hand, mice whose bladder
epithelium has changed to dys-
plasia, carcinoma in situ and in-
vasive tumor by BBN are good
models for human invasive blad-
der carcinomas (Hirose et al.,
1976).  Thus, mice were selected
in the present investigation as
models for invasive bladder car-
cinomas in humans.
In Experiment I, the occur-
rence of carcinomas was signifi-
cantly higher in Group III and sig-
nificantly lower in Group I than in
the other groups.  In Experiment
II, the tumor induction time was
significantly shorter in Group III
and significantly longer in Group
I than in the other groups.  A
previous report showed that both
surgical castration and luteinizing
hormone-releasing hormone ago-
nist  t reatment  s ignif icant ly
reduced the occurrence of carci-
nomas as compared with controls;
thus, surgery and ether anesthesia
had little influence on carcinoma
occurrences (Imada et al., 1997).
Similarly, intramuscular injection
was not found to affect induction
of carcinogenesis (Kono et al.,
1975).  Our findings also showed
that an overdose of testosterone
promotes the occurrence of blad-
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der carcinomas in BBN-induced
mice and that suppression of tes-
tosterone decreases it.
Previously, the effects of tes-
tosterone on bladder carcinogen-
esis in animal models were con-
sidered to suppress the detoxica-
tion of BBN, induce a stimulation
pathway for BBN-proximate car-
cinogen in the liver (Bertram and
Craig, 1972) or increase cell
growth in premalignant lesions of
the bladder epithelium (Okajima
et al., 1975).  Recently, Imada et
al. (1997) demonstrated the exis-
tence of androgen receptors on
the bladder epithelium of mice
and rats using an immunohisto-
chemical staining.  Noronha and
Rao (1986) also reported that sex
hormone receptors were identi-
fied in human advanced transi-
tional cell carcinomas, and di-
hydrotestosterone and testoster-
one receptors were found more
frequently than estrogen recep-
tors.  Although there is no clear
evidence, testosterone may act on
bladder mucosa and promote
bladder carcinogenesis as it does
in prostate cancer.
Previous studies have shown
significant correlations between
PCNA and histological stages or
grades in human bladder cancer
(Waldman et al., 1993; Skopeliou
et al., 1997).  PCNA expression in
rats was also found to gradually
increase as histological stages and
grades advance (Yamashi, 1996).
The present study yielded similar
results, and our findings agreed
significantly with those of the
previous reports.  In Group III,
Fig. 4.  A Grade-3 invasive bladder carcinoma in Group III.  g:  Hematoxylin and eosin staining.  h:  Pro-
liferating cell nuclear antigen-positive cells shown by immunohistochemical staining are significantly more
stained than in Group I (Fig. 3e).  i: Apoptotic cells are almost equal in quantity to in Group I, shown by
terminal-deoxynucleotidyl-transferase (TdT)-mediated dUTP-biotin nick end labeling (Fig. 3f), × 200.
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PCNA showed the highest expression, and in
Group I, the lowest expression among the 3
groups.  These findings support that testos-
terone promotes increased cell proliferation in
BBN-induced mouse bladder carcinogenesis.
Apoptosis is one of the most important
molecular mechanisms in the process of car-
cinogenesis.  Originally, apoptosis is character-
ized by a marked reduction in cell volume and
increase in density.  Apoptotic bodies are histo-
logically characterized by their small size, nu-
clear chromatin condensation, DNA fragmen-
tation and compactness of cytoplasmic organel-
les (Kerr et al., 1972, 1994).  TUNEL was
introduced by Gavriel et al. (1992), and shown
to be able to detect apoptosis cells in routine
formalin-fixed, paraffin-embedded sections.
The extent of apoptosis has been examined in
several experimental tumor types (Aihara et al.,
1994; Tatebe et al., 1996).  The previous studies
reported that the apoptotic index in bladder tu-
mors, such as cell proliferation, indicates a
positive correlation between histological stages
and grades in humans (Koyuncuoglu et al.,
1998) or a negative correlation in rats (Shirai et
al., 1995).  In the present study, the occurrence
of apoptosis in a BBN-treated mouse showed a
negative correlation with histological stage,
grade or proliferation index.  These different re-
sults may be influenced by differences in nu-
merous oncogenes and tumor suppressor genes,
including bcl-2, c-myc, p53, etc.
among the various models.
This is the first study that indi-
cates a correlation between the ef-
fects of testosterone in BBN-induced
mouse bladder carcinogenesis and
cell proliferation and apoptosis.
Among the 3 groups, the proliferation
index of invasive carcinomas was
significantly higher in Group III and
lower in Group I than in other groups;
on the other hand, no significant
difference was observed in apoptotic
index.  These results suggest that one
of the effects of testosterone in BBN-
induced mouse bladder carcinogene-
sis increases cell proliferation rather
than decreasing apoptosis, and that
this effect promotes mouse bladder carcino-
genesis.
However, the exact mechanisms by which
testosterone promotes bladder carcinogenesis
are not known.  Thus, it is necessary to investi-
gate the relationship between testosterone and
growth factor production in the process of
bladder carcinogenesis.  In the future, it might
be possible to perform a chemoprevention trial
on bladder cancer with hormonal therapy,
provided that further investigations clarify the
mechanisms related to the effects of testos-
terone on human bladder carcinogenesis.
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